Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C3AR1 | Q16581 | 1/20 | 0.41 |
| ▸ | FURIN | P09958 | 9/20 | 0.40 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.36 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KLK7 | P49862 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24191073 | 0.99 | C3AR1 (0.42) | C3AR1FURINQRFPRPRSS1CTDSP1 | |
| Trifluoroacetic Acid SCHEMBL23630136 | 0.93 | QRFPR (0.39) | C3AR1FURINQRFPRPRSS1CTDSP1 | |
| SCHEMBL29385639 | 0.92 | C3AR1 (0.45) | C3AR1FURINCTDSP1NOD1SHMT1 | |
| SCHEMBL6850333 | 0.90 | FURIN (0.40) | FURINQRFPRPRSS1NOD1 | |
| SCHEMBL6850341 | 0.90 | FURIN (0.40) | FURINQRFPRPRSS1NOD1 | |
| SCHEMBL30317564 | 0.90 | C3AR1 (0.42) | C3AR1FURINQRFPRPRSS1CTDSP1 | |
| SCHEMBL24191266 | 0.89 | C3AR1 (0.40) | C3AR1QRFPR | |
| SCHEMBL29620243 | 0.88 | C3AR1 (0.42) | C3AR1FURINPRSS1CTDSP1NOD1 | |
| SCHEMBL29392024 | 0.88 | FOLH1 (0.44) | FURINPRSS1CPB2SLC15A2 | |
| SCHEMBL2369351 | 0.87 | C3AR1 (0.39) | C3AR1FURINPRSS1CTDSP1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4549460-A1 | IMMOBILIZED ENDOGLYCOSIDASE FUSION PROTEIN AND USE THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2025-05-07 | — | — | EP | claimed |
| CN-119300838-A | Oligosaccharide linker, linker-cargo comprising oligosaccharide linker and antibody conjugated drug with sugar chain remodelling, preparation method and use thereof | 启德医药科技（苏州）有限公司 | 2025-01-10 | — | — | CN | claimed |
| US-20250312476-A1 | OLIGOSACCHARIDE LINKER, LINKER-PAYLOAD COMPRISING THE SAME AND GLYCAN CHAIN-REMODELED ANTIBODY-DRUG CONJUGATE, PREPARATION METHODS AND USES THEREOF | GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) | 2025-10-09 | — | — | US | disclosed |
| CN-119300838-A | Oligosaccharide linker, linker-cargo comprising oligosaccharide linker and antibody conjugated drug with sugar chain remodelling, preparation method and use thereof | 启德医药科技（苏州）有限公司 | 2025-01-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250312476-A1 | OLIGOSACCHARIDE LINKER, LINKER-PAYLOAD COMPRISING THE SAME AND GLYCAN CHAIN-REMODELED ANTIBODY-DRUG CONJUGATE, PREPARATION METHODS AND USES THEREOF | FUT5, FUT6, STT3B | C3AR1 1106/4885FURIN 318/4885QRFPR 1487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.